Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

366

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Major Depressive Disorder
Interventions
DRUG

Vortioxetine

Vortioxetine tablets

DRUG

Placebo

Vortioxetine placebo

Trial Locations (32)

Unknown

Inzai-shi

Noda

Fukuoka

Kitakyushu-shi

Annaka-shi

Fujioka-shi

Takasaki-shi

Hatsukaichi-shi

Hiroshima

Sapporo

Amagasaki-shi

Kobe

Ibaraki

Fujisawa-shi

Kawasaki-shi

Sagamihara-shi

Yokohama

Osaka

Kumamoto

Kyoto

Kurashiki-shi

Osaka

Fukaya-shi

Saitama

Utsunomiya

Anan-shi

Tokushisma-shi

Hachioji-shi

Katsushika-ku

Musashino-shi

Tokyo

Nanyo-shi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY